Session

PP 05 IBD (Posters)

DOUBLE-EDGED SWORD EFFECT OF GLUCOCORTICOIDS IN EXPERIMENTAL COLITIS – IS THERE A ROLE OF RAPAMYCIN?
DOUBLE-EDGED SWORD EFFECT OF GLUCOCORTICOIDS IN EXPERIMENTAL COLITIS – IS THERE A ROLE OF RAPAMYCIN?

IBDQ AND NON-INVASIVE MACHINE LEARNING-BASED PREDICTION OF ENDOSCOPIC ACTIVITY IN ULCERATIVE COLITIS
IBDQ AND NON-INVASIVE MACHINE LEARNING-BASED PREDICTION OF ENDOSCOPIC ACTIVITY IN ULCERATIVE COLITIS

PROTEIN FINGERPRINT ASSAYS REFLECTING NEUTROPHIL ACTIVITY, MUCOSAL DAMAGE, AND TISSUE FIBROSIS ARE SURROGATE BIOMARKERS FOR MUCOSAL HEALING IN PEDIATRIC CROHN’S DISEASE
PROTEIN FINGERPRINT ASSAYS REFLECTING NEUTROPHIL ACTIVITY, MUCOSAL DAMAGE, AND TISSUE FIBROSIS ARE SURROGATE BIOMARKERS FOR MUCOSAL HEALING IN PEDIATRIC CROHN’S DISEASE

COMBINATION THERAPY WITH BIOLOGICS AND SMALL MOLECULES IN REFRACTORY INFLAMMATORY BOWEL DISEASE (IBD): A SINGLE TERTIARY-CENTRE EXPERIENCE
COMBINATION THERAPY WITH BIOLOGICS AND SMALL MOLECULES IN REFRACTORY INFLAMMATORY BOWEL DISEASE (IBD): A SINGLE TERTIARY-CENTRE EXPERIENCE

BIOELECTRICAL IMPEDANCE ANALYSIS AND HEMATOLOGICAL SCALES - A BRAND NEW COMBINATION FOR THE EVALUATION OF IBD PATIENTS?
BIOELECTRICAL IMPEDANCE ANALYSIS AND HEMATOLOGICAL SCALES - A BRAND NEW COMBINATION FOR THE EVALUATION OF IBD PATIENTS?

SEMI-AUTOMATED SEGMENTATION OF INFLAMED BOWEL WALL ON NONCONTRAST T2-WEIGHTED MRI FOR STREAMLINED VOLUMETRIC ASSESSMENT OF CROHN’S DISEASE
SEMI-AUTOMATED SEGMENTATION OF INFLAMED BOWEL WALL ON NONCONTRAST T2-WEIGHTED MRI FOR STREAMLINED VOLUMETRIC ASSESSMENT OF CROHN’S DISEASE

CORTICOSTEROID-FREE REMISSION IN ANTI-TNF FAILED CROHN’S DISEASE PATIENTS TREATED WITH VEDOLIZUMAB AS SECOND-LINE BIOLOGIC THERAPY: A REAL WORLD DATA REVIEW
CORTICOSTEROID-FREE REMISSION IN ANTI-TNF FAILED CROHN’S DISEASE PATIENTS TREATED WITH VEDOLIZUMAB AS SECOND-LINE BIOLOGIC THERAPY: A REAL WORLD DATA REVIEW

DISTINCTIVE MICROBIOTA AND DENDRITIC CELL ACTIVATION CHARACTERIZE THE APPENDIX OF ULCERATIVE COLITIS PATIENTS
DISTINCTIVE MICROBIOTA AND DENDRITIC CELL ACTIVATION CHARACTERIZE THE APPENDIX OF ULCERATIVE COLITIS PATIENTS

NOTCH PATHWAY: THERAPEUTIC TARGET IN INTESTINAL FIBROSIS ASSOCIATED WITH CROHN'S DISEASE
NOTCH PATHWAY: THERAPEUTIC TARGET IN INTESTINAL FIBROSIS ASSOCIATED WITH CROHN'S DISEASE

IMMUNE AND NON IMMUNE CHANGES FOLLOWING FMT IN EXPERIMENTAL COLITIS: EMERGING PATHWAYS OF FMT-DERIVED MUCOSAL HEALING
IMMUNE AND NON IMMUNE CHANGES FOLLOWING FMT IN EXPERIMENTAL COLITIS: EMERGING PATHWAYS OF FMT-DERIVED MUCOSAL HEALING

EFFECT OF VITAMIN D SUPPLEMENTATION ON VITAMIN D, ITS METABOLITES AND VITAMIN D BINDING PROTEIN IN INFLAMMATORY BOWEL DISEASE: DOES INFLAMMATION MATTER?
EFFECT OF VITAMIN D SUPPLEMENTATION ON VITAMIN D, ITS METABOLITES AND VITAMIN D BINDING PROTEIN IN INFLAMMATORY BOWEL DISEASE: DOES INFLAMMATION MATTER?

IL-33 ACTIVATES CD73-EXPRESSING CELLS PROMOTING TUMORIGENESIS DURING COLITIS-ASSOCIATED COLORECTAL CANCER
IL-33 ACTIVATES CD73-EXPRESSING CELLS PROMOTING TUMORIGENESIS DURING COLITIS-ASSOCIATED COLORECTAL CANCER

MACHINE LEARNING APPROACH TO PREDICT TREATMENT OUTCOMES OF ANTI-TUMOR NECROSIS FACTOR -Α ANTIBODY AGENTS FOR PATIENTS WITH CROHN’S DISEASE
MACHINE LEARNING APPROACH TO PREDICT TREATMENT OUTCOMES OF ANTI-TUMOR NECROSIS FACTOR -Α ANTIBODY AGENTS FOR PATIENTS WITH CROHN’S DISEASE

PREDICTORS OF ANTI-TNF TREATMENT FAILURE IN INFLAMMATORY BOWEL DISEASE PATIENTS NAÏVE TO BIOLOGIC DRUGS: A 20-YEAR REAL WORLD STUDY
PREDICTORS OF ANTI-TNF TREATMENT FAILURE IN INFLAMMATORY BOWEL DISEASE PATIENTS NAÏVE TO BIOLOGIC DRUGS: A 20-YEAR REAL WORLD STUDY

UTILITY OF BIOMARKERS IN PREDICTING DISEASE ACTIVITY AND LONG-TERM OUTCOME IN ULCERATIVE COLITIS – A LONGITUDINAL FOLLOW UP STUDY
UTILITY OF BIOMARKERS IN PREDICTING DISEASE ACTIVITY AND LONG-TERM OUTCOME IN ULCERATIVE COLITIS – A LONGITUDINAL FOLLOW UP STUDY

PROPHYLAXIS OF POST-OPERATIVE RELAPSE IN PATIENTS WITH CROHN’S DISEASE; INDICATIONS AND PRACTICE
PROPHYLAXIS OF POST-OPERATIVE RELAPSE IN PATIENTS WITH CROHN’S DISEASE; INDICATIONS AND PRACTICE

REINDUCTION AND INTENSIFICATION STRATEGY WITH USTEKINUMAB IN IBD PATIENTS, A SINGLE CENTER REAL LIFE EXPERIENCE
REINDUCTION AND INTENSIFICATION STRATEGY WITH USTEKINUMAB IN IBD PATIENTS, A SINGLE CENTER REAL LIFE EXPERIENCE

A BIOMARKER OF EARLY MUCOSAL DESTRUCTION: NEUTROPHIL-MEDIATED TYPE IV COLLAGEN DEGRADATION IS ELEVATED IN PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS
A BIOMARKER OF EARLY MUCOSAL DESTRUCTION: NEUTROPHIL-MEDIATED TYPE IV COLLAGEN DEGRADATION IS ELEVATED IN PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS

THE IMPORTANCE OF ANTITNF LEVELS DURING THE INDUCTION IN PERIANAL CROHN´S DISEASE
THE IMPORTANCE OF ANTITNF LEVELS DURING THE INDUCTION IN PERIANAL CROHN´S DISEASE

MAGNETIC RESONANCE IMAGING-BASED MEASURE OF FIBROSIS IN ENTERIC CROHN’S DISEASE
MAGNETIC RESONANCE IMAGING-BASED MEASURE OF FIBROSIS IN ENTERIC CROHN’S DISEASE

Item 481 - 500 / 826
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
25
26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42